Cystotech ApS

Cystotech ApS

Private
AarhusHealthcare & Life Scienceshttps://www.cystotech.com/

Last Round

VC Round

Jan 15, 2026

Total Funding Raised

$750,000

Company Overview

Cystotech ApS is a medical technology company that provides an AI-based decision support platform for bladder cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Medical Imaging, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

bladder cancer detectioncystoscopy AIurology AIsoftware as a medical deviceSaMDmedical imaging AIclinical decision supportdiagnostic AIcomputer visionMedTechCE marked medical deviceon-premise softwaredevice-agnosticdigital 3D mapping

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cystotech ApS Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cystotech ApS Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 15, 2026
VC RoundMay 5, 2025
Pre SeedAug 1, 2023
SeedMay 1, 2022

Key People

Founding team and executive leadership

Anna Munk

Co-Chief Executive Officer & Co-founder

Founding Team

Claus Hansen

Co-CEO, Co-founder & Member Of The Board

Founding Team

Cystotech ApS Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 15, 2026

    $1.86M round led by Delphinus Venture Capital

  • May 5, 2025

    $1.13M round completed.

Cystotech ApS Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cystotech ApS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cystotech ApS's valuation, stock price, and market status.

Firmographic Details

HeadquartersAarhus
Employee Range21
Year Founded2021
Last FundingJan 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.